The Nasdaq 100 (^NDX) is known for housing some of the most innovative and fastest-growing companies in the market. But not every stock in the index is a winner - some are struggling with slowing growth, increasing competition, or unsustainable valuations.

Investing in Nasdaq 100 stocks isn’t just about picking big names - it’s about finding the right ones, and that’s where StockStory comes in. That said, here is one Nasdaq 100 stock that could lead the market and two that may struggle.

Two Stocks to Sell:

Keurig Dr Pepper (KDP)

Market Cap: $38.18 billion

Born out of a 2018 merger between Keurig Green Mountain and Dr Pepper Snapple, Keurig Dr Pepper (NASDAQ: KDP) is a consumer staples powerhouse boasting a portfolio of beverages including sodas, coffees, and juices.

Why Is KDP Not Exciting?

1. Scale is a double-edged sword because it limits the company’s growth potential compared to its smaller competitors, as reflected in its below-average annual revenue increases of 5.8% for the last three years
2. Day-to-day expenses have swelled relative to revenue over the last year as its operating margin fell by 5.9 percentage points
3. Low returns on capital reflect management’s struggle to allocate funds effectively

Keurig Dr Pepper’s stock price of $28.02 implies a valuation ratio of 13.2x forward P/E. If you’re considering KDP for your portfolio, see our FREE research report to learn more.

Biogen (BIIB)

Market Cap: $25.25 billion

Founded in 1978 and pioneering treatments for some of medicine's most complex challenges, Biogen (NASDAQ: BIIB) develops and markets therapies for neurological conditions, including multiple sclerosis, Alzheimer's disease, spinal muscular atrophy, and rare diseases.

Why Does BIIB Fall Short?

1. Products and services are facing significant end-market challenges during this cycle as sales have declined by 6.7% annually over the last five years
2. Projected sales decline of 9.4% for the next 12 months points to an even tougher demand environment ahead
3. Earnings per share have dipped by 13.2% annually over the past five years, which is concerning because stock prices follow EPS over the long term

Biogen is trading at $169.78 per share, or 13.3x forward P/E. To fully understand why you should be careful with BIIB, check out our full research report (it’s free for active Edge members).

One Stock to Buy:

DoorDash (DASH)

Market Cap: $95.38 billion

Founded by Stanford students with the intent to build “the local, on-demand FedEx", DoorDash (NYSE: DASH) operates an on-demand food delivery platform.

Why Will DASH Outperform?

1. Orders are rising, meaning the company can increase revenue without incurring additional customer acquisition costs if it can cross-sell additional products and features
2. Additional sales over the last three years increased its profitability as the 1,009% annual growth in its earnings per share outpaced its revenue
3. Free cash flow margin expanded by 12.6 percentage points over the last few years, providing additional flexibility for investments and share buybacks/dividends

At $230.92 per share, DoorDash trades at 28.1x forward EV/EBITDA. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free for active Edge members.

High-Quality Stocks for All Market Conditions

If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.

Don’t wait for the next volatility shock. Check out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today.